TFN momentum stock pick Sequenom, Inc. (Nasdaq:SQNM) up 20% in a day
Posted June 5, 2008
Baltimore — (TFN): Our momentum stock pick Sequenom, Inc. (Nasdaq:SQNM), which had soared over 20% on news that its nucleic acid technology is able to detect Down’s syndrome, continued to pack on the shekels today, gaining an additional 20%.
The stock traded at $9.24 at the time we recommended it on June 4. It went as high as $11.30 today.
We will hold on to the stock at least until tomorrow. We believe that the news value of its announcement will continue to percolate through the media, supporting the stock at between $10.50-11 in the short term.
We’d take profits between $11.40-11.50 if we can
****Make sure you sign up for our FREE TFN News Feed for breaking news, special reports and new financial videos. Sign up through your favorite reader here. Or, if you prefer, have the feed delivered to your email.
Related Articles
- Sequenom (SQNM:Nasdaq) gains 20% on Down’s Syndrome discovery - June 4, 2008
- Take profits on US Dataworks (UDW) - August 16, 2008
- Bailout Bonus: National City (NCC) up by over 65% - October 1, 2008
- Genesee & Wyoming Railroad (GWR:NYSE) is getting closer to our sell target - July 22, 2008
- Las Vegas Sands (LVS) in quicksand again - November 19, 2008


TFN provides an independent and practical perspective on the U.S. and global investment markets.
Add New Comment
Thanks. Your comment is awaiting approval by a moderator.
Do you already have an account? Log in and claim this comment.
Add New Comment